EN DE
STOCK COMPARISON

CSPC Pharmaceutical Group vs Eli Lilly and: Fair Value & Quality

Both stocks run through our valuation models. Here is how CSPC Pharmaceutical Group (1093) and Eli Lilly and (LLY) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees CSPC Pharmaceutical Group as the less overvalued of the two: CSPC Pharmaceutical Group trades at HK$8.50 versus a fair value of HK$7.14 (-16%), while Eli Lilly and trades at $1,192 versus $397 (-67%).
CSPC Pharmaceutical Group
1093.HK · HKD · Health Care
-16%
upside to fair value
overvalued
PriceHK$8.50
Fair ValueHK$7.14
Quality58/100
Eli Lilly and
LLY · USD · Health Care
-67%
upside to fair value
overvalued
Price$1,192
Fair Value$397
Quality75/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

CSPC Pharmaceutical GroupEli Lilly and
Valuation
20.8×P/E (TTM)42.2×
3.63×P/S (TTM)14.67×
2.79×P/B39.94×
18.8×EV/EBITDA30.2×
0.33×PEG1.54×
3.3%Dividend yield0.5%
HK$0.26Dividend per share$6.23
Profitability
13%Net margin35%
15%Operating margin49%
10%Return on equity107%
5%Return on assets21%
Growth
-8%Revenue growth (YoY)56%
-7.1%Avg. growth/yr (3Y)31.7%
1.4%Avg. growth/yr (5Y)21.6%
Balance & size
—Debt / equity1.54×
$12BMarket cap$1.1T
weakGrowth qualitymixed

Eli Lilly and leads: 6 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

CSPC Pharmaceutical Groupof which business quality 67 · market factors 42 Eli Lilly andof which business quality 65 · market factors 81
ProfitabilityMargins and returns on capital today
53
85
Quality GrowthAre margins and returns improving?
10
86
CashflowEarnings quality: real cash, not paper profit
69
51
Fin. StrengthBalance sheet, leverage, solvency risk
89
53
InvestmentDisciplined investing over empire-building
76
15
Low VolatilityCalm price path (market factor)
52
73
MomentumPrice trend over the last 3–12 months (market factor)
37
78
52W MomentumDistance to the 52-week high (market factor)
40
94
Net IssuanceBuybacks instead of dilution
99
93

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

CSPC Pharmaceutical Group

DCF ModelsHK$8.42
Earnings-BasedHK$4.61
Dividend DiscountHK$3.75
MultiplesHK$6.08
Asset-BasedHK$1.95
Growth DCFHK$7.92
Economic ProfitHK$3.55
Growth EarningsHK$6.71

21 of 26 models see the stock below the current price.

Eli Lilly and

DCF Models$323
Earnings-Based$239
Dividend Discount$115
Multiples$303
Asset-Based$19.94
Growth DCF$171
Economic Profit$347
Growth Earnings$353

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

CSPC Pharmaceutical Group
Bear HK$5.48Fair Value HK$7.14Bull HK$8.81
HK$8.50 = current price (white tick)
Eli Lilly and
Bear $222Fair Value $397Bull $582
$1,192 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

CSPC Pharmaceutical Group · Health Care

Quality score58 · above median
Fair value upside-16% · above median

Eli Lilly and · Health Care

Quality score75 · Top 25%
Fair value upside-67% · bottom 25%

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees CSPC Pharmaceutical Group as the less overvalued of the two: CSPC Pharmaceutical Group trades at HK$8.50 versus a fair value of HK$7.14 (-16%), while Eli Lilly and trades at $1,192 versus $397 (-67%).

Eli Lilly and has the higher quality score (75/100).

See the full analysis →
CSPC Pharmaceutical Group · Eli Lilly and

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to CSPC Pharmaceutical Group

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Eli Lilly and

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.